FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 301:68-73 July 12, 1979 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The mechanism of recumbent hypertension induced by fludrocortisone was studied in seven patients with orthostatic hypotension. All showed increases in blood pressure in the recumbent and standing positions, and hypertensive levels were achieved on recumbency in four of them. Hypertensive retinopathy developed in two patients and cardiomegaly in one. Initial blood-pressure elevations were associated with sodium retention and plasma-volume expansion. However, with long-term treatment, plasma volume decreased to control levels despite further blood-pressure increases. Treatment did not affect plasma levels of catecholamines but did enhance pressor responsiveness to infused norepinephrine in some subjects. Hemodynamic studies indicated that hypertension in the recumbent position was related to increases in total peripheral-vascular resistance and not to changes in cardiac output. Clinically, hypertension in the recumbent position is an important risk of fludrocortisone treatment in patients with orthostatic hypotension. This unusual model of chronic mineralocorticoid-induced hypertension is not volume dependent but is related to increased peripheral-vascular resistance.

This article has been cited by other articles:

• Freeman, R. (2008). Neurogenic Orthostatic Hypotension. NEJM 358: 615-624 [Full Text]  
• Lipp, A., Sandroni, P., Ahlskog, J. E., Maraganore, D. M., Shults, C. W., Low, P. A. (2007). Calf venous compliance in multiple system atrophy. Am. J. Physiol. Heart Circ. Physiol. 293: H260-H265 [Abstract] [Full Text]  
• Singer, W., Sandroni, P., Opfer-Gehrking, T. L., Suarez, G. A., Klein, C. M., Hines, S., O'Brien, P. C., Slezak, J., Low, P. A. (2006). Pyridostigmine Treatment Trial in Neurogenic Orthostatic Hypotension. Arch Neurol 63: 513-518 [Abstract] [Full Text]  
• Singer, W, Opfer-Gehrking, T L, McPhee, B R, Hilz, M J, Bharucha, A E, Low, P A (2003). Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J. Neurol. Neurosurg. Psychiatry 74: 1294-1298 [Abstract] [Full Text]  
• Rowe, P. C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B. A., Soto, N., Hohman, P., Snader, S., Lucas, K. E., Wolff, M., Straus, S. E. (2001). Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue Syndrome: A Randomized Controlled Trial. JAMA 285: 52-59 [Abstract] [Full Text]  
• JORDAN, J., SHANNON, J. R., POHAR, B., PARANJAPE, S. Y., ROBERTSON, D., ROBERTSON, R.-M., BIAGGIONI, I. (1999). Contrasting Effects of Vasodilators on Blood Pressure and Sodium Balance in the Hypertension of Autonomic Failure. J. Am. Soc. Nephrol. 10: 35-42 [Abstract] [Full Text]  
• Shannon, J., Jordan, J., Costa, F., Robertson, R. M., Biaggioni, I. (1997). The Hypertension of Autonomic Failure and Its Treatment. Hypertension 30: 1062-1067 [Abstract] [Full Text]  
• Jacob, G., Shannon, J. R., Black, B., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R. M., Robertson, D. (1997). Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic Tachycardia. Circulation 96: 575-580 [Abstract] [Full Text]  
• Hoeldtke, R. D., Streeten, D. (1993). Treatment of Orthostatic Hypotension with Erythropoietin. NEJM 329: 611-615 [Abstract] [Full Text]